Brazil Diabetic Neuropathy Treatment Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$106.9

Forecast, 2030 (US$M)

$182.4

CAGR, 2024 - 2030

7.9%

Report Coverage

Brazil

Brazil diabetic neuropathy treatment market, 2018-2030 (US$M)

Related Markets

Global Diabetic Neuropathy Treatment Industry

North America Diabetic Neuropathy Treatment Market Outlook

U.S. Diabetic Neuropathy Treatment Market Outlook

Canada Diabetic Neuropathy Treatment Market Outlook

Europe Diabetic Neuropathy Treatment Market Outlook

Germany Diabetic Neuropathy Treatment Market Outlook

France Diabetic Neuropathy Treatment Market Outlook

Italy Diabetic Neuropathy Treatment Market Outlook

Spain Diabetic Neuropathy Treatment Market Outlook

Denmark Diabetic Neuropathy Treatment Market Outlook

Sweden Diabetic Neuropathy Treatment Market Outlook

Norway Diabetic Neuropathy Treatment Market Outlook

UK Diabetic Neuropathy Treatment Market Outlook

Asia Pacific Diabetic Neuropathy Treatment Market Outlook

Japan Diabetic Neuropathy Treatment Market Outlook

China Diabetic Neuropathy Treatment Market Outlook

India Diabetic Neuropathy Treatment Market Outlook

Australia Diabetic Neuropathy Treatment Market Outlook

South Korea Diabetic Neuropathy Treatment Market Outlook

Thailand Diabetic Neuropathy Treatment Market Outlook

Latin America Diabetic Neuropathy Treatment Market Outlook

Mexico Diabetic Neuropathy Treatment Market Outlook

Argentina Diabetic Neuropathy Treatment Market Outlook

MEA Diabetic Neuropathy Treatment Market Outlook

South Africa Diabetic Neuropathy Treatment Market Outlook

Saudi Arabia Diabetic Neuropathy Treatment Market Outlook

UAE Diabetic Neuropathy Treatment Market Outlook

Kuwait Diabetic Neuropathy Treatment Market Outlook

Brazil diabetic neuropathy treatment market highlights

The Brazil diabetic neuropathy treatment market generated a revenue of USD 106.9 million in 2023 and is expected to reach USD 182.4 million by 2030.
The Brazil market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
In terms of segment, peripheral neuropathy was the largest revenue generating disorder type in 2023.
Autonomic Neuropathy is the most lucrative disorder type segment registering the fastest growth during the forecast period.

Diabetic neuropathy treatment market data book summary

Market revenue in 2023	USD 106.9 million
Market revenue in 2030	USD 182.4 million
Growth rate	7.9% (CAGR from 2023 to 2030)
Largest segment	Peripheral neuropathy
Fastest growing segment	Autonomic Neuropathy
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy
Key market players worldwide	Abbott Laboratories, Eli Lilly and Co, Pfizer Inc, Janssen Pharmaceuticals, Lupin, Astellas Pharma Inc, Glenmark Pharmaceuticals, Boehringer Ingelheim, Novartis AG ADR

Other key industry trends

In terms of revenue, Brazil accounted for 2.5% of the global diabetic neuropathy treatment market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil diabetic neuropathy treatment market is projected to lead the regional market in terms of revenue in 2030.
Mexico is the fastest growing regional market in Latin America and is projected to reach USD 97.5 million by 2030.

Key Regions: U.S. , UK , Japan , UAE , Canada

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Diabetic Neuropathy Treatment Market Scope

Diabetic neuropathy treatment market segmentation & scope

Diabetic Neuropathy Treatment Market Companies

Name	Profile	# Employees	HQ	Website

Brazil diabetic neuropathy treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic neuropathy treatment market will help companies and investors design strategic landscapes.

Peripheral neuropathy was the largest segment with a revenue share of 63.05% in 2023. Horizon Databook has segmented the Brazil diabetic neuropathy treatment market based on peripheral neuropathy, autonomic neuropathy, proximal neuropathy, focal neuropathy covering the revenue growth of each sub-segment from 2018 to 2030.

Brazil Diabetic Neuropathy Treatment Disorder Type Outlook (Revenue, USD Million, 2018-2030)
- Peripheral Neuropathy
- Autonomic Neuropathy
- Proximal Neuropathy
- Focal Neuropathy
Brazil Diabetic Neuropathy Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Capsaicin
- Opioid
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Antidepressants
- Other Drug Class
Brazil Diabetic Neuropathy Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others Distribution Channel

Reasons to subscribe to Brazil diabetic neuropathy treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil diabetic neuropathy treatment market databook

Our clientele includes a mix of diabetic neuropathy treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil diabetic neuropathy treatment market, including forecasts for subscribers. This country databook contains high-level insights into Brazil diabetic neuropathy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.